| This article was first published on les Nouvelles, March 2026 edition. In the high-stakes biotechnology and pharmaceutical industries, and in their emerging offshoots like the fast-growing psychedelics space, patents are both a cornerstone of innovation and a potential latent source of risk. At the heart of this dynamic lie prior art and freedom-to-operate […]
Pharmaceutical
Expert Testimony Insights on Pharmaceutical Litigation – Commercial Success Nexus
At Ocean Tomo, our pharmaceutical practice has seen substantial growth within the last few years. In addition to more traditional damage expert opinions, clients are increasingly asking Ocean Tomo experts for commercial success opinions. Here, the issue of nexus typically becomes the battleground that the commercial success war is fought over. Delving into commercial success […]